To Dodge Mensing, Plaintiffs May Target Foreign Drugmakers

Law360, New York (October 29, 2013, 8:40 PM EDT) -- Though an Arkansas federal court dismissed drug defect claims against an Indian manufacturer on Monday, attorneys believe more and more plaintiffs injured by generic drugs could go after foreign contract manufacturers in their desperate attempt to find defendants unprotected by the U.S. Supreme Court's Mensing and Bartlett decisions.

U.S. District Judge J. Leon Holmes ruled that his court lacked jurisdiction over Claris Lifesciences Ltd. and its subsidiary Claris Lifesciences Inc. in two lawsuits brought by Arkansas residents claiming the antibiotic metronidazole that they had ingested was...
To view the full article, register now.

Documents

Related

Sections

Case Information

Case Title

Woods et al v. Claris Lifescience Limited et al


Case Number

4:13-cv-00286

Court

Arkansas Eastern

Nature of Suit

Personal Inj. Prod. Liability

Judge

J. Leon Holmes

Date Filed

May 13, 2013


Case Title

Brinker et al v. Claris Lifescience Limited et al


Case Number

4:13-cv-00302

Court

Arkansas Eastern

Nature of Suit

Personal Inj. Prod. Liability

Judge

J. Leon Holmes

Date Filed

May 20, 2013

Law Firms

Companies

Government Agencies

UK Financial Services

UK Financial Services

Read Our Latest UK Financial Services Coverage

Financial Services Law360 UK provides breaking news and analysis on the financial sector. Coverage includes UK and European Union policy, enforcement, and litigation involving banks, asset management firms, and other financial services organizations.